Ron Bentsur - May 19, 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Stock symbol
NVCT
Transactions as of
May 19, 2022
Transactions value $
$20,070
Form type
4
Date filed
5/23/2022, 08:32 AM
Previous filing
May 19, 2022
Next filing
May 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3.79K +200 +0.01% $18.95 2.96M May 19, 2022 Direct F1
transaction NVCT Common Stock Purchase $16.3K +1K +0.03% $16.28 2.96M May 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.